The Trump administration could be stuck with the expensive decision by Biden’s HHS to expand Medicare coverage of anti-obesity medications. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
